Cannabis Hyperemesis Syndrome Survey |
Tell us what you think! Your feedback is important to us.
The Canadian Centre on Substance Use and Addiction, Canadian Society of Hospital Pharmacists Ontario Branch, Canadian Pharmacists Association, Canadian Patient Safety Institute, Patients for Patient Safety Canada, Northwest Telepharmacy Solutions and ISMP Canada have collaborated together to create a handout for patients about cannabinoid hyperemesis syndrome (CHS).
Thank you for taking the time to answer this survey based on your experience of using the handout.